Tramadol Hydrochloride Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 50 mg, 100 mg, 150 mg, 200 mg, 300 mg
Reference Brands: Ultram(US); Tramacet, Ultracet(EU)
Category:
Analgesic
Tramadol hydrochloride activates opioid receptors and inhibits noradrenaline and serotonin reuptake, reducing pain signals centrally. Benefits include effective relief from moderate to severe pain, improved mobility, and long-term pain management. It offers rapid onset, with fewer gastrointestinal side effects, making it a versatile option for acute and chronic pain treatment.
Tramadol Hydrochloride tablets is available in Oral Tablets
and strengths such as 50 mg, 100 mg, 150 mg, 200 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tramadol Hydrochloride tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tramadol Hydrochloride tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tramadol Hydrochloride tablets are approved in the US and EU for moderate to severe pain management. In the US, brands like Ultram are regulated by the FDA, with extensive clinical data supporting safety and efficacy, and registered as controlled substances due to dependence potential. In the EU, EMA-regulated products such as Ultracet and generics require dossiers demonstrating safety, efficacy, and quality. Both regions enforce strict control measures and pharmacovigilance for ongoing safety monitoring. For assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective pain relief.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing